Delivery Order 36C24E26D0008-36C24E26N0165
Award Date 7/1/26
Potential Completion Date 6/30/27
Potential Value $8.4M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60654, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 1, awarded a $2.7 million firm fixed price delivery order to Tempus AI, Inc. (doing business as Tempus Labs Inc.) for TASSO+ sequencing services supporting the MVP (Million Veteran Program) initiative. The contract was awarded on March 2, 2026, with an ultimate completion date of March 1, 2027, and carries no set-aside designation. This delivery order is issued under Tempus's larger Indefinite Delivery Contract with the...
- Tempus AI, Inc. (doing business as Tempus Labs Inc.) was awarded a delivery order valued at $293,819 for tumor normal matched genomic testing services by a civilian federal agency. This firm fixed price delivery order, issued on September 26, 2022, with an ultimate completion date of September 25, 2023, represents work performed under Tempus's larger Indefinite Delivery Contract with the Department of Veterans Affairs. The contract does not utilize a set-aside designation. Performance will be...
- Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
- The Department of Veterans Affairs (VA) awarded a $2,022,406 Firm Fixed Price Delivery Order contract to Tempus Labs Inc., doing business as Tempus, to provide Tumor Normal Matched Genomic Testing Services. Tempus will perform genomic testing services on tumor and normal tissue samples from VA patients to identify genomic variants that may be targeted for precision cancer therapies. The contract has a one-year period of performance starting January 28, 2022 through January 27, 2023 and will be...
- This federal contract award to Tempus AI, Inc. (doing business as Tempus Labs Inc.) is for tumor normal matched genomic testing services for the U.S. Department of Veterans Affairs (VA). The $5,718,045.00 firm fixed price delivery order contract, awarded on January 28, 2025, has a performance period extending through January 27, 2027. Tempus Labs Inc. is an experienced provider of genomic sequencing and precision medicine services to the VA, holding a larger $64,296,441.00 Indefinite Delivery...
- Modification P9 to a delivery order issued by a civilian federal agency updates contract terms by changing the contracting officer and incorporating the Veterans Affairs Acquisition Regulation (VAAR) Clause 852.222-71 Compliance with Executive Order 13899, while also adding Clinical Line Item (CLIN) 4009 and updating CLIN 4006. This delivery order, valued at $5.53M on a firm fixed-price basis, was awarded on January 28, 2026, to Tempus AI, Inc. (doing business as Tempus Labs Inc.), a...
- This federal contract award is for TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES, awarded by the U.S. Department of Veterans Affairs (VA) to Tempus AI, Inc., doing business as Tempus Labs Inc. The contract has a ceiling value of $7,989,504.00 and is a firm fixed price delivery order with a performance period through January 27, 2024. Tempus Labs Inc. is the prime contractor and specializes in precision medicine and genomic sequencing services. The company has established itself as a key provider...
- The Department of Veterans Affairs Veterans Integrated Service Network 7 awarded a $66,869 firm fixed-price purchase order to Tempus AI, Inc. (doing business as Tempus Labs Inc.) on September 30, 2024, for DNA methylation and genome-wide association study services. The contract supports a research initiative evaluating epigenetic aging changes in HIV-positive veterans who participated in a telehealth-delivered high-intensity exercise study. The work will be performed in Chicago, Illinois, and...
- This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
- This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters (VA HQ) to Akesogen, Inc.'s Tempus Labs division. The contract, valued at $10,477,738.83, tasks Tempus Labs with providing genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services in support of the VA's biomedical research programs. The work is performed at the VA HQ in Washington, D.C. with...
- 36C24E26D0008Indefinite Delivery Contract
- 36C24E26D0008-36C24E26N0165Delivery Order
Veterans Integrated Service Network 1 issued an $8.39 million delivery order to Tempus AI, Inc. on July 1, 2026, for TASSO+ assay testing supporting the MVP program, with final completion June 30, 2027. The order is issued under Tempus AI's existing Indefinite Delivery Contract with the VA, valued at $64.3 million and extending through January 27, 2027. Tempus AI specializes in precision medicine and advanced genomic sequencing services, delivering tumor-normal matched genomic testing and comprehensive genomic profiling to support oncology-related patient care and research across VA facilities. Place of performance is Chicago, IL. The order is priced on a firm fixed price basis with no set-aside applied.
Generated 6/30/26, 11:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4m | 6/28/26 |